Bioproduction Forum
How to switch from early clinical phases to industrialisation and commercial production of biotherapy products
At the Bioproduction Forum organised by A3P and MabDesign, Géry Van Vyncht will present jointly with Peggy Sander (ILS) on behalf of the GIC Biotherapy Processes.
The talk will introduce the "Technical Guide V2", developed by their industry working group, to support the transition of biotherapy products from late development to commercial manufacturing.
Building on Guide V1, which focuses on early development, this update addresses late‑stage development from Phase II/III to commercialisation. It structures requirements by development phase and key topics such as CMC, quality, analytics and manufacturing, combining practical guidance with real‑world insights for scaling up.
Speakers
- Géry Van Vyncht – Scientific Director, Quality Assistance
- Peggy Sander – Pharma Biotech Process Expert, Ingérop Life Sciences
Practical information
- Tuesday June 2
- 6.00-6.30 PM